Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents

被引:316
作者
Ota, Tsuguhito [1 ]
Gayet, Constance [1 ]
Ginsberg, Henry N. [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
关键词
D O I
10.1172/JCI32752
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ER stress can cause hepatic insulin resistance and steatosis. Increased VLDL secretion could protect the liver from ER stress-induced steatosis, but the effect of lipid-induced ER stress on the secretion of VLDL is unknown. To determine the effect of lipids on hepatic ER stress and VLDL secretion, we treated McA-RH7777 liver cells with free fatty acids. Prolonged exposure increased cell triglycerides, induced steatosis, and increased ER stress. Effects on apoB100 secretion, which is required for VLDL assembly, were parabolic, with moderate free fatty acid exposure increasing apoB100 secretion, while greater lipid loading inhibited apoB100 secretion. This decreased secretion at higher lipid levels was due to increased protein degradation through both proteasomal and nonproteasomal pathways and was dependent on the induction of ER stress. These findings were supported in vivo, where intravenous infusion of oleic acid (OA) in mice increased ER stress in a duration-dependent manner. apoB secretion was again parabolic, stimulated by moderate, but not prolonged, OA infusion. Inhibition of ER stress was able to restore OA-stimulated apoB secretion after prolonged OA infusion. These results suggest that excessive ER stress in response to increased hepatic lipids may decrease the ability of the liver to secrete triglycerides by limiting apoB secretion, potentially worsening steatosis.
引用
收藏
页码:316 / 332
页数:17
相关论文
共 75 条
[1]   Overproduction of large VLDL particles is driven by increased liver fat content in man [J].
Adiels, M ;
Taskinen, MR ;
Packard, C ;
Caslake, MJ ;
Soro-Paavonen, A ;
Westerbacka, J ;
Vehkavaara, S ;
Hakkinen, A ;
Olofsson, SO ;
Yki-Jarvinen, H ;
Borén, J .
DIABETOLOGIA, 2006, 49 (04) :755-765
[2]   Mechanisms of metabolic dyslipidemia in insulin resistant states: Deregulation of hepatic and intestinal lipoprotein secretion [J].
Avramoglu, RK ;
Qiu, W ;
Adeli, K .
FRONTIERS IN BIOSCIENCE, 2003, 8 :D464-D476
[3]  
BARR J E, 1979, Pharmacology Biochemistry and Behavior, V11, P115, DOI 10.1016/0091-3057(79)90307-1
[4]   A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death [J].
Borradaile, NM ;
Buhman, KK ;
Listenberger, LL ;
Magee, CJ ;
Morimoto, ETA ;
Ory, DS ;
Schaffer, JE .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (02) :770-778
[5]   VLDL OUTPUT BY HEPATOCYTES FROM OBESE ZUCKER RATS IS RESISTANT TO THE INHIBITORY EFFECT OF INSULIN [J].
BOURGEOIS, CS ;
WIGGINS, D ;
HEMS, R ;
GIBBONS, GF .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 269 (02) :E208-E215
[6]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[7]   Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z:: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency [J].
Burrows, JAJ ;
Willis, LK ;
Perlmutter, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1796-1801
[8]   IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA [J].
Calfon, M ;
Zeng, HQ ;
Urano, F ;
Till, JH ;
Hubbard, SR ;
Harding, HP ;
Clark, SG ;
Ron, D .
NATURE, 2002, 415 (6867) :92-96
[9]   Selective inhibition of eukaryotic translation initiation factor 2α dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis [J].
Cnop, Miriam ;
Ladriere, Laurence ;
Hekerman, Paul ;
Ortis, Fernanda ;
Cardozo, Alessandra K. ;
Dogusan, Zeynep ;
Flamez, Daisy ;
Boyce, Michael ;
Yuan, Junying ;
Eizirik, Decio L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (06) :3989-3997
[10]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909